Kornitzer Capital Management »

Halozyme Therapeutics shares owned by Kornitzer Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Kornitzer Capital Management from 13F filings

Historical chart of Kornitzer Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Kornitzer Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Kornitzer Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $20M 485k 40.68
2023-12-31 $18M 475k 36.96
2023-09-30 $17M 452k 38.20
2023-06-30 $15M 427k 36.07
2023-03-31 $16M 424k 38.19
2022-12-31 $17M 305k 56.90
2022-09-30 $18M 448k 39.54
2022-06-30 $20M 448k 44.00
2022-03-31 $22M 547k 39.88
2021-12-31 $22M 547k 40.21
2021-09-30 $19M 465k 40.68
2021-06-30 $21M 465k 45.41
2021-03-31 $17M 412k 41.69
2020-12-31 $18M 412k 42.71
2020-09-30 $12M 462k 26.28
2020-06-30 $13M 467k 26.81
2020-03-31 $8.5M 471k 17.99
2019-12-31 $4.7M 267k 17.73